Retraction notices

Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder

Type

Retraction

Notice date

3/11/2024 0:00

Journal

CNS Neuroscience & Therapeutics

Publisher

Wiley

Notice DOI

10.1111/cns.14667

Original paper DOI

10.1111/cns.13731

Reasons

• Investigation by Journal/Publisher
• Investigation by Third Party
• Unreliable Data
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• CNS Neuroscience & Therapeutics